JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores
JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an...
Top Biopharma Companies Show A Dip In Market Cap For Q3
The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from...
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by...
The 8th edition of PharmaLytica Expo opened its doors to industry professionals at the Bombay...
Vetter publishes first sustainability report
Vetter, a global leading Contract Development and Manufacturing Organization (CDMO), has published its first sustainability...
Dr. Reddys Says Russia Sales Booming As Big Pharma Retreats
While many western biopharma businesses have shied away from Russia since its invasion of Ukraine,...
Commercializing Biopharmaceutical Innovation In A New Era
The new era in biopharmaceutical development promises to usher in a slew of breakthrough medicines,...
Pfizer Shells Out $11.6 Bn. For Biohaven- Largest Since 2016
Pfizer will pay $11.6 billion for migraine medicine manufacturer Biohaven Pharmaceutical, signifying the company's largest...
Japan Drug Lobby Asserts Pricing Scheme Driving Drug Crisis
For the first time in the week starting May 16th, Japan's three major pharmaceutical trade...
Amid Global Setbacks, Indian Pharma Exports Grow In 2021-22
The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in...
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for...